Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2026)

Camp4 Therapeutics has disclosed Net Cash Flow across 4 years of filings, most recently posting -$10.9 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$10.9 million, up 25.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.8 million (up 123.38% YoY), and the FY2025 annual result was $46.0 million, up 79.46% from the prior year.
• Net Cash Flow came in at -$10.9 million for Q1 2026 at Camp4 Therapeutics, down from $34.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $61.5 million in Q4 2024 to a low of -$14.7 million in Q1 2025.
• The 4-year median for Net Cash Flow is -$10.6 million (2025), against an average of $4.9 million.
• Across the five-year window, Net Cash Flow jumped 608.82% in 2024 and sank 43.37% in 2025, its largest moves.
• Camp4 Therapeutics' Net Cash Flow stood at -$12.1 million in 2023, then surged by 608.82% to $61.5 million in 2024, then tumbled by 43.37% to $34.8 million in 2025, then slumped by 131.42% to -$10.9 million in 2026.
• The last three Net Cash Flow figures came in at -$10.9 million (Q1 2026), $34.8 million (Q4 2025), and $36.2 million (Q3 2025), per Business Quant data.